UISH 001

Drug Profile

UISH 001

Alternative Names: BTL-hs; UISH-001

Latest Information Update: 22 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Beech Tree Labs
  • Class Antidiuretics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Muscular dystrophies
  • No development reported Urinary incontinence

Most Recent Events

  • 22 Sep 2015 No recent reports on development identified - Phase-I/II for Urinary incontinence in USA (Sublingual)
  • 06 Nov 2012 Efficacy & adverse events data from a phase I/IIa trial in Urinary incontinence released by Beech Tree Labs
  • 31 May 2012 Beech Tree Labs completes a phase I/IIa trial in Urinary incontinence in USA (NCT01340066)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top